About the Company
We do not have any company description for Ikena Oncology, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Ikena Oncology, Inc.
Ikena Oncology, Inc. (IKNA) Reports Q1 Loss, Tops Revenue Estimates
Ikena Oncology, Inc. (IKNA) delivered earnings and revenue surprises of -11.90% and 4.57%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Ikena Oncology (IKNA) This Earnings ... - Nasdaq
Investors are always looking for stocks that are poised to beat at earnings season and Ikena Oncology, Inc. IKNA may be one such company. The firm has earnings coming up pretty soon, and events ...
Could The Ikena Oncology, Inc. (NASDAQ:IKNA) Ownership Structure Tell ...
Our data suggests that insiders own under 1% of Ikena Oncology, Inc. in their own names. It has a market capitalization of just US$604m, and the board has only US$414k worth of shares in their own ...
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock ...
BOSTON and SOUTH SAN FRANCISCO, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (IKNA) (Nasdaq: IKNA, “Ikena”), a targeted oncology company forging new territory in patient ...
Ikena Oncology Analyst Ratings and Price Targets | NASDAQ:IKNA | Benzinga
With an average price target of $3.33 between HC Wainwright & Co., HC Wainwright & Co., and Wedbush, there's an implied 152.53% upside for Ikena Oncology Inc from these most-recent analyst ratings.
Ikena Oncology, Inc.: Ikena Oncology and Inmagene Biopharmaceuticals ...
Ad hoc-Mitteilungen: Aktien»Nachrichten»IKENA ONCOLOGY AKTIE»Ikena Oncology, Inc.: Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement IKENA ...
Ikena Oncology, Inc.: Ikena Oncology Announces Stockholder Approval of ...
Combined Company to Trade on Nasdaq Under Ticker "IMA" Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock BOSTON and SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc.
Ikena Oncology Reports Second Quarter 2022 Financial Results and ...
BOSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (IKNA), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced financial results for ...
Similar Companies
Loading the latest forecasts...